Visualisation and stereological assessment of blood and lymphatic vessels

Histology and Histopathology

Volumn 26, Issue 6, 2011, Pages 781-796

  Lokmic, Zerina ^a   Mitchell, Geraldine M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Endothelial cell; Mural cell and basement membrane component identification; Stereology; Three dimensional vascular casts; Two dimensional sectioning; Visualisation of vascular and lymphatic vessels

Indexed keywords

ANIMAL; BLOOD VESSEL; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; METHODOLOGY; REVIEW; THREE DIMENSIONAL IMAGING;

ANIMALS; BLOOD VESSELS; HUMANS; IMAGING, THREE-DIMENSIONAL; IMMUNOHISTOCHEMISTRY; LYMPHATIC VESSELS;

EID: 79959916279     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. Abramoff M.D., Magelhaes P.J. and Ram S.J. (2004). Image processing with ImageJ. Biophotonics Intl. 11, 36-42.
2. Abruzzo T., Tumialan L., Chaalala C., Kim S., Guldberg R.E., Lin A., Leach J., Khoury J.C., Morgan A.E. and Cawley C.M. (2008). Microscopic computed tomography imaging of the cerebral circulation in mice: feasibility and pitfalls. Synapse 62, 557-565.
3. Alitalo K., Tammela T. and Petrova T.V. (2005). Lymphangiogenesis in development and human disease. Nature 438, 946-952.
4. Alroy J., Goyal V. and Skutelsky E. (1987). Lectin histochemistry of mammalian endothelium. Histochemistry 86, 603-607.
5. Andrade C.F., Wong A.P., Waddell T.K., Keshavjee S. and Liu M. (2007). Cell-based tissue engineering for lung regeneration. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L510-518.
6. Arkudas A., Beier J.P., Pryymachuk G., Hoereth T., Bleiziffer O., Polykandriotis E., Hess A., Gulle H., Horch R.E. and Kneser U. (2010). Automatic Quantitative Micro-Computed Tomography Evaluation of Angiogenesis in an Axially Vascularized Tissue-Engineered Bone Construct. Tissue Eng. Part C Methods 16, 1503-1514.
7. Baluk P. and McDonald D.M. (2008). Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann. N. Y. Acad. Sci. 1131, 1-12.
8. Baluk P., Fuxe J., Hashizume H., Romano T., Lashnits E., Butz S., Vestweber D., Corada M., Molendini C., Dejana E. and McDonald D. M. (2007). Functionally specialised junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204, 2349-2362.
9. Barth P.J., Ebrahimsade S., Hellinger A., Moll R. and Ramaswamy A. (2002). CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch. 440, 128-133.
10. Baumheter S., Singer M.S., Henzel W., Hemmerich S., Renz M., Rosen S.D. and Lasky L.A. (1993). Binding of L-selectin to the vascular sialomucin CD34. Science 262, 436-438.
11. Baumhueter S., Dybdal N., Kyle C. and Lasky L.A. (1994). Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood 84, 2554-2565.
12. Bellhorn M.B., Bellhorn R.W. and Poll D.S. (1977). Permeability of fluorescein-labelled dextrans in fundus fluorescein angiography of rats and birds. Exp. Eye Res. 24, 595-605.
13. Bergers G., Song S., Meyer-Morse N., Bergsland E. and Hanahan D. (2003). Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 111,1287-1295.
14. Bonner-Weir S. and Orci L. (1982). New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31, 883-889.
15. Breiteneder-Geleff S., Matsui K., Soleiman A., Meraner P., Poczewski H., Kalt R., Schaffner G. and Kerjaschki D. (1997). Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am. J. Pathol. 151, 1141-1152.
16. Carpenter A.M. (1979). Stereology. Definition and historic background. J. Histochem. Cytochem. 27, 1535.
17. Clarijs R., Schalkwijk L., Hofmann U.B., Ruiter D.J. and de Waal R.M. (2002). Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res. 62, 7059-7065.
18. Clasper S. and Jackson D.G. (2009). Immunohistochemical methods for measuring tissue lymphangiogenesis. Methods Mol. Biol. 467, 79-91.
19. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P.N., Traas J., Schugar R., Deasy B.M., Badylak S., Buhring H.J., Giacobino J.P., Lazzari L., Huard J. and Peault B. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301-313.
20. Cruz-Orive L.M. and Weibel E.R. (1990). Recent stereological methods for cell biology: a brief survey. Am. J. Physiol. 258, L148-156.
21. Czymmek K., Wagner R., Hossler F.E. and Kao R. (2001). Imaging and volumetric quantitation of vascular corrosion casts with laser confocal microscopy. Microsc. Microanal. 6, 562-563.
22. Dallas N.A., Samuel S., Xia L., Fan F., Gray M.J., Lim S.J. and Ellis L.L. (2008). Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin. Cancer Res. 14, 1931-1937.
23. Debbage P.L., Solder E., Seidl S., Hutzler P., Hugl B., Ofner D. and Kreczy A. (2001). Intravital lectin perfusion analysis of vascular permeability in human micro-and macro-blood vessels. Histochem. Cell Biol. 116, 349-359.
24. DeLisser H.M., Christofidou-Solomidou M., Strieter R.M., Burdick M. D., Robinson C.S., Wexler R.S., Kerr J.S., Garlanda C., Merwin J.R., Madri J.A. and Albelda S.M. (1997). Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am. J. Pathol. 151, 671-677.
25. Dellavalle A., Sampaolesi M., Tonlorenzi R., Tagliafico E., Sacchetti B., Perani L., Innocenzi A., Galvez B.G., Messina G., Morosetti R., Li S., Belicchi M., Peretti G., Chamberlain J.S., Wright W.E., Torrente Y., Ferrari S., Bianco P. and Cossu G. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 9, 255-267.
26. Diaz-Flores L., Gutierrez R., Madrid J.F., Varela H., Valladares F., Acosta E., Martin-Vassalo P. and Diaz-Flores L. Jr. (2009). Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol. Histopathol. 24, 909-969.
27. Dockery P. and Fraher J. (2007). The quantification of vascular beds: A stereological approach. Exp. Mol. Pathol. 110-120.
28. Dumont D.J., Jussila L., Taipale J., Lymboussaki A., Mustonen T., Pajusola K., Breitman M. and Alitalo K. (1998). Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282, 946-949.
29. Engelhardt B., Conley F.K. and Butcher E.C. (1994). Cell adhesion molecules on vessels during inflammation in the mouse central nervous system. J. Neuroimmunol. 51, 199-208.
30. Eppel G.A., Jacono D.L., Shirai M., Umetani K., Evans R.G. and Pearson J.T. (2009). Contrast angiography of the rat renal microcirculation in vivo using synchrotron radiation. Am. J. Physiol. Renal Physiol. 296, F1023-1031.
31. Ezaki T., Baluk P., Thurston G., La Barbara A., Woo C. and McDonald D.M. (2001). Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am. J. Pathol 158, 2043-2055.
32. Farr A.G., Berry M.L., Kim A., Nelson A.J., Welch M.P. and Aruffo A. (1992). Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues. J. Exp. Med. 176, 1477-1482.
33. Fina L., Molgaard H.V., Robertson D., Bradley N.J., Monaghan P., Delia D., Sutherland D.R., Baker M.A. and Greaves M.F. (1990). Expression of the CD34 gene in vascular endothelial cells. Blood 75, 2417-2426.
34. Garcia Y., Breen A., Burugapalli K., Dockery P. and Pandit A. (2007). Stereological methods to assess tissue response for tissueengineered scaffolds. Biomaterials 28, 175-186.
35. Greene A.S., Lombard J.H., Cowley A.W. Jr and Hansen-Smith F.M. (1990). Microvessel changes in hypertension measured by Griffonia simplicifolia I lectin. Hypertension 15, 779-783.
36. Halin C., Rodrigo Mora J., Sumen C. and von Andrian U.H. (2005). In vivo imaging of lymphocyte trafficking. Annu. Rev. Cell Dev. Biol. 21, 581-603.
37. Hall J.E. (2010). Overview of the circulation; medical biophysics of pressure, flow and resistance. In Guyton and Hall Textbook of Medical Physiology. 12 ed. Saunders Elsevier. Philadelphia. pp. 157-166.
38. Hallmann R., Horn N., Selg M., Wendler O., Pausch F. and Sorokin L.M. (2005). Expression and function of laminins in the embryonic and mature vasculature. Physiol. Rev. 85, 979-1000.
39. Hallmann R., Mayer D.N., Berg E.L., Broermann R. and Butcher E.C. (1995). Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier. Dev. Dyn. 202, 325-332.
40. Hickey M.J., Wilson Y., Hurley J.V. and Morrison W.A. (1998). Mode of vascularization of control and basic fibroblast growth factorstimulated prefabricated skin flaps. Plast. Reconstr. Surg. 101, 1296-1304.
41. Holthofer H., Virtanen I., Kariniemi A.L., Hormia M., Linder E. and Miettinen A. (1982). Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab. Invest. 47, 60-66.
42. Hossler F.E. and Douglas J.E. (2001). Vascular corrosion casting: review of advantages and limitations in the application of some simple quantitative methods. Microsc. Microanal. 7, 253-264.
43. Howard C.V. and Reed M.G. (2005). Unbiased Stereology. Second edition. Oxon: BIOS Scientific Publishers, Taylor & Francis Group.
44. Hughes S. and Chan-Ling T. (2004). Characterization of smooth muscle cell and pericyte differentiation in the rat retina in vivo. Invest. Ophthalmol. Vis. Sci. 45, 2795-2806.
45. Hyde D.M., Tyler N.K. and Plopper C.G. (2007). Morphometry of the respiratory tract: avoiding the sampling, size, orientation, and reference traps. Toxicol. Pathol. 35, 41-48.
46. Ilan N. and Madri J.A. (2003). PECAM-1: old friend, new partners. Curr. Opin. Cell Biol. 15, 515-524.
47. Jackson D.G. (2009). Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol. Rev. 230, 216-231.
48. Jiao C., Bronner S., Mercer K.L., Sheriff D.D., Schatteman G.C. and Dunnwald M. (2004). Epidermal cells accelerate the restoration of the blood flow in diabetic ischemic limbs. J. Cell Sci. 117, 1055-1063.
49. Jurisic G. and Detmar M. (2009). Lymphatic endothelium in health and disease. Cell Tissue Res. 335, 97-108.
50. Kahn H.J., Bailey D. and Marks A. (2002). Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod. Pathol. 15, 434-440.
51. Kaipainen A., Korhonen J., Mustonen T., van Hinsbergh V.W., Fang G.H., Dumont D., Breitman M. and Alitalo K. (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92, 3566-3570.
52. Keuschnigg J., Henttinen T., Auvinen K., Karikoski M., Salmi M. and Jalkanen S. (2009). The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood 114, 478-484.
53. Ko T., Muramatsu T. and Shirai T. (1996). Distribution of lectin UEA-I in trichilemmal carcinoma, squamous cell carcinoma, and other epithelial tumors of the skin. J. Dermatol. 23, 389-393.
54. Krause D.S., Fackler M.J., Civin C.I. and May W.S. (1996). CD34: structure, biology, and clinical utility. Blood 87, 1-13.
55. Kurozumi K., Hardcastle J., Thakur R., Yang M., Christoforidis G., Fulci G., Hochberg F.H., Weissleder R., Carson W., Chiocca E.A. and Kaur B. (2007). Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy. J. Natl. Cancer Inst. 99, 1768-1781.
56. Kutzner H. (1993). Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J. Am. Acad. Dermatol. 28, 613-617.
57. Lamagna C. and Bergers G. (2006). The bone marrow constitutes a reservoir of pericyte progenitors. J. Leukoc. Biol. 80, 677-681.
58. Lee M.C., Turcinov D. and Damjanov I. (1987). Lectins as markers for eosinophilic leukocytes. Histochemistry 86, 269-273.
59. Leenstra S., Das P.K., Troost D., Bosch D.A., Claessen N. and Becker A.E. (1990). PAL-E, monoclonal antibody with immunoreactivity for endothelium specific to brain tumours. Lancet 335, 671.
60. Li Y., Song Y., Zhao L., Gaidosh G., Laties A.M. and Wen R. (2008). Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI. Nat. Protoc. 3, 1703-1708.
61. Lokmic Z., Stillaert F., Morrison W.A., Thompson E.W. and Mitchell G.M. (2007). An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J. 21, 511-522.
62. Lokmic Z. and Mitchell G.M. (2008). Engineering the microcirculation. Tissue Eng. Part B Rev. 14, 87-103.
63. Lokmic Z., Thomas J.L., Morrison W.A., Thompson E.W. and Mitchell G.M. (2008a). An endogenously deposited fibrin scaffold determines construct size in the surgically created arteriovenous loop chamber model of tissue engineering. J. Vasc. Surg. 48, 974-985.
64. Lokmic Z., Lammermann T., Sixt M., Cardell S., Hallmann R. and Sorokin L. (2008b). The extracellular matrix of the spleen as a potential organizer of immune cell compartments. Semin. Immunol. 20, 4-13.
65. MacDonald I.C. and Chambers A.F. (2008). Chapter 9. Intravital videomicroscopy in angiogenesis research. Methods Enzymol. 444, 201-230.
66. Makinen T., Adams R.H., Bailey J., Lu Q., Ziemiecki A., Alitalo K., Klein, R. and Wilkinson G.A. (2005). PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 19, 397-410.
67. Matsumoto H., Kumon Y., Watanabe H., Ohnishi T., Shudou M., Ii C., Takahashi H., Imai Y. and Tanaka J. (2007). Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions. J. Neurosci. Res. 85, 994-1009.
68. Matsumoto M., Tanaka T., Yamamoto T., Noiri E., Miyata T., Inagi R., Fujita T. and Nangaku M. (2004). Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J. Am. Soc. Nephrol. 15, 1574-1581.
69. McDonald D.M. and Choyke P.L. (2003). Imaging of angiogenesis: from microscope to clinic. Nat. Med, 9, 713-725.
70. Michel R.P. and Cruz-Orive L.M. (1988). Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J. Microsc. 150, 117-136.
71. Miettinen M., Lindenmayer A.E. and Chaubal A. (1994). Endothelial cell markers CD31, CD34, and BNH9 antibody to H-and Y-antigens evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod. Pathol. 7, 82-90.
72. Mouta Carreira C., Nasser S.M., di Tomaso E., Padera T.P., Boucher Y., Tomarev S.I. and Jain R.K. (2001). LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 61, 8079-8084.
73. Muller A.M., Skrzynski C., Nesslinger M., Skipka G. and Muller K.M. (2002). Correlation of age with in vivo expression of endothelial markers. Exp. Gerontol. 37, 713-719.
74. Muller A.M., Skrzynski C., Skipka G. and Muller K.M. (2002a). Expression of von Willebrand factor by human pulmonary endothelial cells in vivo. Respiration 69, 526-533.
75. Nachbar M.S., Oppenheim J.D. and Thomas J.O. (1980). Lectins in the U.S. Diet. Isolation and characterization of a lectin from the tomato (Lycopersicon esculentum). J. Biol. Chem. 255, 2056-2061.
76. Newman P.J. and Albelda S.M. (1992). Cellular and molecular aspects of PECAM-1. Nouv. Rev. Fr. Hematol. 34 Suppl, S9-13.
77. Nielsen J.S. and McNagny K.M. (2008). Novel functions of the CD34 family. J. Cell Sci. 121, 3683-3692.
78. Niemela H., Elima K., Henttinen T., Irjala H., Salmi M. and Jalkanen S. (2005). Molecular identification of PAL-E, a widely used endothelialcell marker. Blood 106, 3405-3409.
79. Nyengaard J.R. and Gundersen H.J. (2006). Direct and efficient stereological estimation of total cell quantities using electron microscopy. J. Microsc. 222, 182-187.
80. Ocak I., Baluk P., Barrett T., McDonald D.M. and Choyke P. (2007). The biologic basis of in vivo angiogenesis imaging. Front. Biosci. 12, 3601-3616.
81. Pajusola K., Aprelikova, O., Korhonen J., Kaipainen A., Pertovaara L., Alitalo R. and Alitalo K. (1992). FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 52, 5738-5743.
82. Panchuk-Voloshina N., Haugland R.P., Bishop-Stewart J., Bhalgat M. K., Millard P.J., Mao F., Leung W.Y. and Haugland R.P. (1999). Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J. Histochem. Cytochem. 47, 1179-1188.
83. Parsons-Wingerter P., Lwai, B., Yang, M.C., Elliott, K.E., Milaninia, A., Redlitz, A., Clark, J.I. and Sage E.H. (1998). A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvasc. Res. 55, 201-214.
84. Partanen T.A., Arola J., Saaristo A., Jussila L., Ora A., Miettinen M., Stacker S.A., Achen M.G. and Alitalo K. (2000). VEGF-C and VEGFD expression in neuroendocrine cells and their receptor, VEGFR-3 in fenestrated blood vessels in human tissues. FASEB J. 14, 2087-2096.
85. Pflicke H. and Sixt M. (2009). Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J. Exp. Med. 206, 2925-2935.
86. Prevo R., Banerji S., Ferguson D.J., Clasper S. and Jackson D.G. (2001). Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276, 19420-19430.
87. Pusztaszeri M.P., Seelentag W. and Bosman F.T. (2006). Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J. Histochem. Cytochem. 54, 385-395.
88. Rabkin M.D., Bellhorn M.B. and Bellhorn R.W. (1977). Selected molecular weight dextrans for in vivo permeability studies of rat retinal vascular disease. Exp. Eye Res. 24, 607-612.
89. Roozendaal R., Mempel T. R., Pitcher L. A., Gonzalez S.F., Verschoor A., Mebius R.E., von Andrian U.H. and Carrol M.C. (2009). Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity 30, 264-276.
90. Rophael J.A., Craft R.O., Palmer J.A., Hussey A.J., Thomas G.P., Morrison W.A., Penington A.J. and Mitchell G.M. (2007). Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis. Am. J. Pathol. 171, 2048-2057.
91. Sadler J.E. (1998). Biochemistry and genetics of von Willebrand factor. Annu. Rev. Biochem. 67, 395-424.
92. Schacht V., Dadras S.S., Johnson L.A., Jackson D.G., Hong Y.K. and Detmar M. (2005). Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am. J. Pathol. 166, 913-921.
93. Schacht V., Ramirez M.I., Hong Y. K., Hirakawa S., Feng D., Harvey N., Williams M., Dvorak A.M., Dvorak H.F., Oliver G. and Detmar M. (2003). T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22, 3546-3556.
94. Scherle W. (1970). A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26, 57-60.
95. Schlingemann R.O., Dingjan G.M., Emeis J.J., Blok J., Warnaar S.O. and Ruiter D.J. (1985). Monoclonal antibody PAL-E specific for endothelium. Lab. Invest. 52, 71-76.
96. Sharma R., Wendt J.A., Rasmussen J.C., Adams K.E., Marshall M.V. and Sevick-Muraca E.M. (2008). New horizons for imaging lymphatic function. Ann. NY Acad. Sci. 1131, 13-36.
97. Sharon N. and Lis H. (2001). The structural basis for carbohydrate recognition by lectins. Adv. Exp. Med. Biol. 491, 1-16.
98. Shayan R., Karnezis T., Tsantikos E., Williams S. P., Runting A.S., Ashton M.W., Achen M.G., Hibbs M.L. and Stacker S.A. (2007). A system for quantifying the patterning of the lymphatic vasculature. Growth Factors 25, 417-425.
99. Sixt M., Kanazawa N., Selg M., Samson T., Roos G., Reinhardt D.P., Pabst R., Lutz M. B. and Sorokin L. (2005). The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22, 19-29.
100. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R. and D'Amore P.A. (1994). Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101-111.
101. Streit W.J. and Kreutzberg G.W. (1987). Lectin binding by resting and reactive microglia. J. Neurocytol. 16, 249-260.
102. Suster S. and Wong T.Y. (1994). On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations. Am. J. Dermatopathol. 16, 355-363.
103. van de Rijn M., Hendrickson M.R. and Rouse R.V. (1994a). CD34 expression by gastrointestinal tract stromal tumors. Hum. Pathol. 25, 766-771.
104. van de Rijn M., Lombard C.M. and Rouse R.V. (1994b). Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung. Am. J. Surg. Pathol. 18, 814-820.
105. Verli F.D., Rossi-Schneider T.R., Schneider F.L., Yurgel L.S. and de Souza M.A. (2007). Vascular corrosion casting technique steps. Scanning 29, 128-132.
106. Vickerman M.B., Keith P.A., McKay T.L., Gedeon D.J., Watanabe M., Montano M., Karunamuni G., Keiser P.K., Sears J.E., Ebrahem Q., Ribita D., Hylton A.G. and Parsons-Wingerter P. (2009). VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks. Anat. Rec. (Hoboken) 292, 320-332.
107. Wagner R.C., Czymmek K. and Hossler F.E. (2006). Confocal microscopy, computer modeling and quantification of glomerular vascular corrosion casts. Microsc. Microanal. 12, 262-268.
108. Weibel E.R. (1969). Stereological principles for morphometry in electron microscopic cytology. Int. Rev. Cytol. 26, 235-302.
109. Weibel E.R. (1972). The value of stereology in analysing structure and function of cells and organs. J. Microsc. 95, 3-13.
110. Weibel E.R. (1975). Quantitation in morphology: possibilities and limits. Beitr. Pathol. 155, 1-17.
111. Weibel E.R. (1989). Measuring through the microscope: development and evolution of stereological methods. J. Microsc. 155, 393-403.
112. Weibel E.R. and Gomez D.M. (1962). A principle for counting tissue structures on random sections. J. Appl. Physiol. 17, 343-348.
113. Weibel E.R., Untersee P., Gil, J. and Zulauf M. (1973). Morphometric estimation of pulmonary diffusion capacity. VI. Effect of varying positive pressure inflation of air spaces. Respir. Physiol. 18, 285-308.
114. Weibel E.R., Hsia C.C. and Ochs M. (2007). How much is there really? Why stereology is essential in lung morphometry. J. Appl. Physiol. 102, 459-467.
115. Weidner N. (2008). Measuring intratumoral microvessel density. Methods Enzymol. 444, 305-323.
116. Witgen B.M., Grady M.S., Nyengaard J.R. and Gundersen H.J. (2006). A new fractionator principle with varying sampling fractions: exemplified by estimation of synapse number using electron microscopy. J. Microsc. 222, 251-255.
117. Witte M.H., Jones K., Wilting J., Dictor M., Selg M., McHale N., Gershenwald J.E. and Jackson D.G. (2006). Structure function relationship in the lymphatic system and implications for cancer biology. Cancer Metastasis Rev. 25, 159-184.
118. Woodfin A., Voisin M.B. and Nourshargh S. (2007). PECAM-1: a multifunctional molecule in inflammation and vascular biology. Arterioscler. Thromb. Vasc. Biol. 27, 2514-2523.
119. Xie Q., Chen L., Fu K., Harter J., Young K.H., Sunkara J., Novak D., Villanueva-Siles E. and Ratech H. (2008). Podoplanin (d2-40): a new immunohistochemical marker for reactive follicular dendritic cells and follicular dendritic cell sarcomas. Int. J. Clin. Exp. Pathol. 1, 276-284.
120. Young P.E., Baumhueter S. and Lasky L.A. (1995). The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood 85, 96-105.
121. Zeng Y., Opeskin K., Horvath L.G., Sutherland R.L. and Williams E.D. (2005). Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 65, 222-230.
122. Zhao Y., Xu Y., Zhang B., Wu X., Xu F., Liang W. and Li R. (2010). In vivo generation of thick, vascularized hepatic tissue from collagen hydrogel-based hepatic units. Tissue Eng. Part C Methods 16, 653-659.